Imperial Healthcare NHS Trust
London, United Kingdom
NCT Number: NCT03211507
A case-control study to investigate whether job exposures are an under-recognized cause of idiopathic pulmonary fibrosis (IPF) using an interview to collect information about previous jobs and a blood test to investigate genetic susceptibility.
Looking for future studies?
Notify MeMale
Observational
London, United Kingdom
Idiopathic pulmonary fibrosis (IPF) is a scarring lung disease. It damages the air sacs that allow oxygen to be transferred into the blood and transported to vital organs. These changes make people with IPF cough and feel short of breath. It not known what causes the damage. People who get IPF are usually older than 40; it's a very serious illness that cannot be cured and gets worse over time. Statistics show that IPF is becoming more common in the UK but it's not known why. It can be difficult for doctors to tell if someone has IPF or another disease called asbestosis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
For cases
Inclusion criteria
Exclusion criteria
For controls
Inclusion criteria
Exclusion criteria
Occupational history
To include analysis of known susceptibility markers
Time frame: 2 years
estimated using logistic regression for any vs no asbestos exposure and adjusting for age and smoking status
Time frame: 2 years
estimated using logistic regression for categories of cumulative exposure and adjusting for age and smoking status
Time frame: 2 years
MUC5B rs35705950 and asbestos exposure odds ratio.
Imperial College London
Other
Acronym: IPFJES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02503657
Fibrosis, IPF
Hershey, Pennsylvania, United States
View Trial DetailsNCT06331624
IPF, Idiopathic Pulmonary Fibrosis
Newport Beach, California, United States
View Trial DetailsNCT05353556
IPF, Idiopathic Pulmonary Fibrosis
Izmir, Balcova, Turkey (Türkiye)
View Trial DetailsNCT06747923
IPF, Idiopathic Pulmonary Fibrosis
Goyang, South Korea
View Trial Details